Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for male erectile dysfunction.

Arnold Melman1

  • 1Department of Urology, Albert Einstein College of Medicine, Bronx, NY, USA. ameman@aecom.yu.edu

The Urologic Clinics of North America
|November 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene Therapy for Overactive Bladder: A Review of BK-Channel α-Subunit Gene Transfer.

Therapeutics and clinical risk management·2021
Same author

Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials.

Neurourology and urodynamics·2020
Same author

The Effects of a Genital Vibratory Stimulation Device on Sexual Function and Genital Sensation.

Female pelvic medicine & reconstructive surgery·2016
Same author

Diabetes attenuates urothelial modulation of detrusor contractility and spontaneous activity.

International journal of urology : official journal of the Japanese Urological Association·2014
Same author

Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2014
Same author

Large-conductance calcium-activated potassium channel activity, as determined by whole-cell patch clamp recording, is decreased in urinary bladder smooth muscle cells from male rats with partial urethral obstruction.

BJU international·2012

Gene transfer therapy offers a promising single treatment for genitourinary disorders, potentially restoring bladder and erectile function. Early trials show safe administration, heralding a new era for enduring therapies.

Area of Science:

  • Urology
  • Gene Therapy
  • Regenerative Medicine

Background:

  • Genitourinary smooth muscle disorders impact bladder and erectile function.
  • Current treatments often require daily medication with potential side effects.

Purpose of the Study:

  • To explore the clinical advantages of gene transfer therapy for genitourinary smooth muscle disorders.
  • To introduce novel gene transfer agents for treating these conditions.

Main Methods:

  • Phase 1 clinical trial of hMax-K for erectile dysfunction.
  • Initiation of a Phase 1 clinical trial for hMaxi-K in detrusor overactivity.

Main Results:

  • Demonstrated safe administration of hMax-K in human subjects.

Related Experiment Videos

  • Initiated trials for hMaxi-K, indicating progress in therapeutic development.

    • Conclusions:

    • Gene transfer therapy presents a potential single-treatment solution for genitourinary disorders.
    • This approach may eliminate the need for daily medication and reduce side effects.
    • It enables mechanism-based, patient-specific treatment strategies.